Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephan T Ledderose

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Cancers|July 12, 2025
Expression Profiles of Co-Inhibitory Receptors in Non-Urothelial Bladder Cancer: Preclinical Evidence for the Next Generation of Immune Checkpoint InhibitorsSeverin Rodler, Stephan T Ledderose, Raphaela Waidelich, et al.
HNO|May 17, 2022
[Child with a vascularized throat mass]Veronika Volgger, Stephan T Ledderose, Evelyn Bienenstein, et al.
World Journal of Urology|October 21, 2020
Prognostic value of pretreatment inflammatory markers in variant histologies of the bladder: is inflammation linked to survival after radical cystectomy?Severin Rodler, Alexander Buchner, Stephan T Ledderose, et al.
Diagnostics (Basel, Switzerland)|April 3, 2021
Immature Plasma Cell Myeloma Mimics Metastatic Renal Cell Carcinoma on <sup>18</sup>F-PSMA-1007 PET/CT Due to Endothelial PSMA-ExpressionLena M Mittlmeier, Stephan T Ledderose, Melanie Schott, et al.
Frontiers in Oncology|June 7, 2021
Feasibility of Different Tumor Delineation Approaches for <sup>18</sup>F-PSMA-1007 PET/CT Imaging in Prostate Cancer PatientsLena M Mittlmeier, Matthias Brendel, Leonie Beyer, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 18, 2024
[<sup>68 </sup>Ga]Ga-FAPI-46 PET/CT for locoregional lymph node staging in urothelial carcinoma of the bladder prior to cystectomy: initial experiences from a pilot analysisLena M Unterrainer, Lennert Eismann, Simon Lindner, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 18, 2024
[<sup>68</sup>Ga]Ga-FAPI-46 PET/CT for penile cancer - a feasibility studyLennert Eismann, Stephan T Ledderose, Benazir Enzinger, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 28, 2021
<sup>68</sup>Ga-EMP-100 PET/CT-a novel ligand for visualizing c-MET expression in metastatic renal cell carcinoma-first in-human biodistribution and imaging resultsLena M Mittlmeier, Andrei Todica, Franz-Josef Gildehaus, et al.
European Journal of Nuclear Medicine and Molecular Imaging|April 24, 2025
<sup>68</sup>Ga-FAPI and <sup>18</sup>F-FAPI PET/CT for detection of nodal metastases prior radical cystectomy in high-risk urothelial carcinoma patientsLena M Unterrainer, Hans P Schmid, Sophie C Kunte, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 24, 2022
Feasibility of [<sup>68</sup>Ga]Ga-FAPI-46 PET/CT for detection of nodal and hematogenous spread in high-grade urothelial carcinomaLena M Unterrainer, Simon Lindner, Lennert Eismann, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Cancers|July 12, 2025
Expression Profiles of Co-Inhibitory Receptors in Non-Urothelial Bladder Cancer: Preclinical Evidence for the Next Generation of Immune Checkpoint InhibitorsSeverin Rodler, Stephan T Ledderose, Raphaela Waidelich, et al.
HNO|May 17, 2022
[Child with a vascularized throat mass]Veronika Volgger, Stephan T Ledderose, Evelyn Bienenstein, et al.
World Journal of Urology|October 21, 2020
Prognostic value of pretreatment inflammatory markers in variant histologies of the bladder: is inflammation linked to survival after radical cystectomy?Severin Rodler, Alexander Buchner, Stephan T Ledderose, et al.
Diagnostics (Basel, Switzerland)|April 3, 2021
Immature Plasma Cell Myeloma Mimics Metastatic Renal Cell Carcinoma on <sup>18</sup>F-PSMA-1007 PET/CT Due to Endothelial PSMA-ExpressionLena M Mittlmeier, Stephan T Ledderose, Melanie Schott, et al.
Frontiers in Oncology|June 7, 2021
Feasibility of Different Tumor Delineation Approaches for <sup>18</sup>F-PSMA-1007 PET/CT Imaging in Prostate Cancer PatientsLena M Mittlmeier, Matthias Brendel, Leonie Beyer, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 18, 2024
[<sup>68 </sup>Ga]Ga-FAPI-46 PET/CT for locoregional lymph node staging in urothelial carcinoma of the bladder prior to cystectomy: initial experiences from a pilot analysisLena M Unterrainer, Lennert Eismann, Simon Lindner, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 18, 2024
[<sup>68</sup>Ga]Ga-FAPI-46 PET/CT for penile cancer - a feasibility studyLennert Eismann, Stephan T Ledderose, Benazir Enzinger, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 28, 2021
<sup>68</sup>Ga-EMP-100 PET/CT-a novel ligand for visualizing c-MET expression in metastatic renal cell carcinoma-first in-human biodistribution and imaging resultsLena M Mittlmeier, Andrei Todica, Franz-Josef Gildehaus, et al.
European Journal of Nuclear Medicine and Molecular Imaging|April 24, 2025
<sup>68</sup>Ga-FAPI and <sup>18</sup>F-FAPI PET/CT for detection of nodal metastases prior radical cystectomy in high-risk urothelial carcinoma patientsLena M Unterrainer, Hans P Schmid, Sophie C Kunte, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 24, 2022
Feasibility of [<sup>68</sup>Ga]Ga-FAPI-46 PET/CT for detection of nodal and hematogenous spread in high-grade urothelial carcinomaLena M Unterrainer, Simon Lindner, Lennert Eismann, et al.
Pageof 1